Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
Marina A. Gracheva(Ministry of Health of the Russian Federation), А. Н. Баландина(Ministry of Health of the Russian Federation), Е Б Орел(Ministry of Health of the Russian Federation), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Фазоил И. Атауллаханов(Moscow Institute of Physics and Technology), Ivan D. Tarandovskiy(Ministry of Health of the Russian Federation), Evdokiya S. Urnova(Ministry of Health of the Russian Federation), Elena I. Sinauridze(Unknown)
Cited by 59
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells
|Leukemia|2015|53
Insights on Multiple Myeloma Treatment Strategies
|HemaSphere|2018|53